
CME GROUP INC.
100
Recent news highlights CME Group's Q1 2026 earnings and revenues were below some market expectations, while average daily volume rose year-over-year. Multiple earnings call transcripts for recent quarters are available.
- CME Group reported Q1 2026 revenues of $1.88 billion and net income of $1.15 billion, with EPS of $3.25 basic and $3.18 diluted [S2].
- Clearing and transaction fees increased to $1.54 billion in Q1 2026, with market data and information services revenue at $224 million [S2].
- Average daily volume rose year-over-year despite earnings and revenues being below some market expectations in Q1 2026 [N2][N3].
- The company continues to expand product offerings including micro products, OTC alternatives, and environmental markets [S1].
- Recent earnings call transcripts for Q1 2026 and prior quarters provide detailed insights into company performance and strategy [N4][N5][N6][N7][N8].
CME Group Inc. is a leading global derivatives marketplace operator, providing trading and clearing services across a wide range of asset classes including interest rates, equity indexes, foreign exchange, agricultural commodities, energy, metals, and cryptocurrencies. The company operates multiple exchanges (CME, CBOT, NYMEX, COMEX) and electronic trading platforms such as CME Globex and CME Direct. CME Group also offers market data, benchmark indices, and analytics services. Its clearing house acts as central counterparty to mitigate credit risk. The customer base spans professional traders, financial institutions, corporations, governments, and retail investors. CME Group pursues growth through product innovation, geographic expansion, retail market development, and diversification into environmental and crypto markets. The company maintains robust technology infrastructure and risk management practices to support its operations.
CME Group Inc. operates leading global derivatives exchanges and clearing services, offering a broad portfolio of futures, options, cash, and OTC products across major asset classes. The company reported Q1 2026 revenues of $1.88 billion and net income of $1.15 billion, with EPS of $3.25 basic and $3.18 diluted. Liquidity ratios as of March 31, 2026, show a current ratio of 1.02 and a cash ratio of 0.02. CME Group's strategic initiatives focus on expanding product offerings, global reach, and retail participation, including launching new micro and OTC products and entering environmental and crypto markets. Recent news indicates Q1 2026 earnings and revenues were below some market expectations, though average daily volume increased year-over-year. Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice.
CME Group's extensive product diversification across major asset classes and its leadership in clearing services position it to capture a wide range of market participants. Growth in micro and OTC alternative products, expansion into environmental and crypto markets, and retail-focused initiatives such as the FanDuel joint venture could broaden its customer base. The company's investments in technology and data services enhance its value proposition. Strong liquidity and profitability metrics support operational resilience.
CME Group faces risks from market volatility, regulatory changes, and competition from other exchanges and alternative trading platforms. Technology disruptions or failures could impact trading and clearing operations. Changes in customer behavior or fee structures may affect revenue. Credit and liquidity risks inherent in clearing activities require ongoing management. Economic downturns or reduced trading volumes could pressure financial performance. Legal and compliance risks, including intellectual property challenges, also present potential headwinds.
CME Group's competitive advantages include its broad and diverse portfolio of benchmark derivatives products, deep liquidity across asset classes, and a leading central counterparty clearing house that mitigates counterparty risk. Its extensive electronic trading platforms and global distribution network provide high accessibility and connectivity. The company's intellectual property in benchmark indices and market data services further strengthens its position. Regulatory approvals and exchange memberships create barriers to entry. The scale and diversity of CME Group's offerings and customer base contribute to network effects and market liquidity, reinforcing its moat.
• Market Volatility and Economic Conditions: Fluctuations in commodity, equity, and fixed income prices, as well as economic and political conditions, can impact trading volumes and revenues.
• Regulatory and Compliance Risks: Changes in regulations or failure to comply with regulatory requirements could affect operations and financial results.
• Technology and Operational Risks: Disruptions or failures in trading and clearing systems could impair market access and customer confidence.
• Credit and Liquidity Risks: Risks related to clearing counterparties and margin requirements require effective risk management to prevent financial losses.
• Competition and Market Structure Changes: Competition from other exchanges and alternative trading venues may pressure market share and pricing.
Business trends: Expansion of futures and options products globally, growth in micro and OTC alternative products, and diversification into environmental and crypto markets.
Execution milestones: Launch of new products and services, retail market initiatives including FanDuel joint venture, and maintenance of robust technology and clearing infrastructure.
Key risks: Market volatility, regulatory changes, technology disruptions, credit and liquidity risks inherent in clearing activities, and competitive pressures.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- CME Group Inc. operates global derivatives exchanges including CME, CBOT, NYMEX, and COMEX, offering futures, options, cash and OTC products across major asset classes such as interest rates, equity indexes, foreign exchange, agricultural, energy, metals, and cryptocurrencies [S1].
- The company provides clearing and settlement services through its derivatives clearing house, serving as central counterparty to trades to mitigate counterparty credit risk [S1].
- CME Group offers market data and analytics services, including real-time, historical, and derived data, and distributes proprietary and third-party benchmark indices such as CME Term SOFR [S1].
- The company operates electronic trading platforms including CME Globex and CME Direct, supporting high-speed, low-latency trading and connectivity [S1].
- CME Group's customer base includes professional traders, financial institutions, corporations, governments, and retail investors, with 85% of contract volume in 2025 from exchange members [S1].
- Strategic initiatives include expanding futures and options globally, launching new products (including micro products and OTC alternatives), enhancing retail strategies, and expanding into environmental markets and crypto products [S1].
- In 2025, CME Group recorded record average daily volume of 28.1 million contracts, with significant growth in interest rates, agricultural, energy, and metals products [S1].
- The company has a joint venture with FanDuel to offer prediction markets for retail customers launched in December 2025 [S1].
- CME Group's revenue for Q1 2026 was $1.880 billion, with clearing and transaction fees of $1.543 billion, market data and information services revenue of $224 million, and other revenues of $113 million [S2].
- Operating income for Q1 2026 was $1.310 billion, with total expenses of $570 million [S2].
- Net income for Q1 2026 was $1.154 billion, with basic EPS of $3.25 and diluted EPS of $3.18 [S2].
- Liquidity as of 2026-03-31 included cash and cash equivalents of $2.39 billion, short-term investments of $124 million, current assets of $169.0 billion, current liabilities of $166.0 billion, resulting in a current ratio of 1.02 and a cash ratio of 0.02 [S2].
- Revenue by product line for Q1 2026 included interest rates $521 million, equity indexes $316 million, foreign exchange $57 million, agricultural commodities $168 million, energy $264 million, metals $118 million, BrokerTec fixed income $40 million, EBS foreign exchange $36 million, and interest rate swaps $23 million [S2].
- Revenue recognition is primarily monthly as services are delivered, with some annual license fees recognized over the contract term [S2].
- The company maintains comprehensive business continuity and disaster recovery plans and invests in technology infrastructure to support trading and clearing operations [S1].
- CME Group faces risks including market volatility, regulatory changes, technology disruptions, competition, and credit and liquidity risks associated with clearing activities [S1].
- Recent news highlights include CME Group's Q1 2026 earnings and revenues missing some estimates but with average daily volume rising year-over-year [N2][N3].
- Multiple recent earnings call transcripts for Q1 2026 and prior quarters are publicly available [N4][N5][N6][N7][N8].
Generated 2026-04-24
- N4
- N5
- N6
- N7
- N8
- S1 | 2026-02-26 | 10-K
- S2 | 2026-04-24 | 10-Q
- N1 | 2026-04-23 | www.nasdaq.com | Nasdaq Q1 Earnings & Revenues Beat Estimates, Dividend Raised | https://www.nasdaq.com/articles/nasdaq-q1-earnings-revenues-beat-estimates-dividend-raised
- N2 | 2026-04-22 | www.nasdaq.com | CME Group's Q1 Earnings and Revenues Miss Estimates, ADV Rises Y/Y | https://www.nasdaq.com/articles/cme-groups-q1-earnings-and-revenues-miss-estimates-adv-rises-y-y-0
- N3 | 2026-04-22 | www.nasdaq.com | CME Group's Q1 Earnings and Revenues Miss Estimates, ADV Rises Y/Y | https://www.nasdaq.com/articles/cme-groups-q1-earnings-and-revenues-miss-estimates-adv-rises-y-y
- N4 | 2026-04-22 | www.nasdaq.com | CME (CME) Q3 2024 Earnings Call Transcript | https://www.nasdaq.com/articles/cme-cme-q3-2024-earnings-call-transcript
- N5 | 2026-04-22 | www.nasdaq.com | CME (CME) Q3 2025 Earnings Call Transcript | https://www.nasdaq.com/articles/cme-cme-q3-2025-earnings-call-transcript
- N6 | 2026-04-22 | www.nasdaq.com | CME (CME) Q1 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/cme-cme-q1-2026-earnings-call-transcript
- N7 | 2026-04-22 | www.nasdaq.com | CME (CME) Q4 2024 Earnings Call Transcript | https://www.nasdaq.com/articles/cme-cme-q4-2024-earnings-call-transcript
- N8 | 2026-04-22 | www.nasdaq.com | CME (CME) Q2 2025 Earnings Call Transcript | https://www.nasdaq.com/articles/cme-cme-q2-2025-earnings-call-transcript
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


